Showing results (1871-1880 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|December 25, 2010
Clinical management of treatment-experienced, HIV/AIDS patients in the combination antiretroviral therapy eraMark A Boyd, Andrew M HillPharmacoeconomics|December 25, 2010
Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USAJosephine Mauskopf, Anita Brogan, Silas Martin, et al.Pharmacoeconomics|January 21, 2011
A value set for the EQ-5D based on experienced health states: development and testing for the German populationReiner Leidl, Peter ReitmeirPharmacoeconomics|June 17, 2010
Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision modelJack Brown, Joseph A PaladinoPharmacoeconomics|June 17, 2010
Q-TWiST analysis of patients receiving temsirolimus or interferon alpha for treatment of advanced renal cell carcinomaArthur S Zbrozek, Gary Hudes, Donna Levy, et al.Pharmacoeconomics|June 8, 2010
Assessing the relationship between computational speed and precision: a case study comparing an interpreted versus compiled programming language using a stochastic simulation model in diabetes carePhil McEwan, Klas Bergenheim, Yong Yuan, et al.Pharmacoeconomics|November 18, 2010
Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devicesLizheng Shi, Jinan Liu, Yordanka Koleva, et al.Pharmacoeconomics|November 18, 2010
The cost utility of autologous chondrocytes implantation using ChondroCelect® in symptomatic knee cartilage lesions in BelgiumLaetitia Gerlier, Mark Lamotte, Micheline Wille, et al.Pharmacoeconomics|December 15, 2010
Accounting for the drug life cycle and future drug prices in cost-effectiveness analysisMartin HoylePageof 336